Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Diel

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2008
Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-upI J Diel, A Jaschke, E F Solomayer, et al.
Geburtshilfe Und Frauenheilkunde|December 1, 1990
[The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer]I J Diel, M Kaufmann, S D Costa, et al.
Anticancer Research|June 9, 2016
Management of Metastatic Bone Disease Algorithms for Diagnostics and TreatmentChristian F Jehn, Ingo J Diel, Friedrich Overkamp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patientsE F Solomayer, I J Diel, G Salanti, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|October 23, 1998
[Significance of myoma-induced complications in pregnancy. A comparative analysis of pregnancy course with and without myoma involvement]B Aydeniz, D Wallwiener, C Kocer, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1996
[Change in the spectrum of uterus-preserving myoma operations including endoscopy and dual myoma therapy]D Wallwiener, B Aydeniz, S Rimbach, et al.
Breast Cancer Research and Treatment|August 8, 1998
Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancerE F Solomayer, I J Diel, G C Meyberg, et al.
Zentralblatt Fur Gynakologie|August 15, 1998
[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support]E F Solomayer, I J Diel, G Meyberg, et al.
British Journal of Cancer|March 18, 2004
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studiesJ J Body, I J Diel, M Lichinitzer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2010
Bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance studyIngo J Diel, Andreas H A Kurth, Hans-Bernd Sittig, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2008
Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-upI J Diel, A Jaschke, E F Solomayer, et al.
Geburtshilfe Und Frauenheilkunde|December 1, 1990
[The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer]I J Diel, M Kaufmann, S D Costa, et al.
Anticancer Research|June 9, 2016
Management of Metastatic Bone Disease Algorithms for Diagnostics and TreatmentChristian F Jehn, Ingo J Diel, Friedrich Overkamp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patientsE F Solomayer, I J Diel, G Salanti, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|October 23, 1998
[Significance of myoma-induced complications in pregnancy. A comparative analysis of pregnancy course with and without myoma involvement]B Aydeniz, D Wallwiener, C Kocer, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1996
[Change in the spectrum of uterus-preserving myoma operations including endoscopy and dual myoma therapy]D Wallwiener, B Aydeniz, S Rimbach, et al.
Breast Cancer Research and Treatment|August 8, 1998
Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancerE F Solomayer, I J Diel, G C Meyberg, et al.
Zentralblatt Fur Gynakologie|August 15, 1998
[Complete remission after salvage chemotherapy in metastatic breast carcinoma after failure of induction cycles of planned high dosage chemotherapy with stem cell support]E F Solomayer, I J Diel, G Meyberg, et al.
British Journal of Cancer|March 18, 2004
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studiesJ J Body, I J Diel, M Lichinitzer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2010
Bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance studyIngo J Diel, Andreas H A Kurth, Hans-Bernd Sittig, et al.
Pageof 9